CLOVER HEALTH INVESTMENTS, CORP. /DE — Form 8-K
Filed September 24, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 32/100
What the filing says
Clover Health appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H. to its Board of Directors effective immediately on September 24, 2026. Torricelli, who has served on Clover's insurance subsidiary board since 2022, joins the Audit Committee; Dr. Miller, a MedPAC Commissioner and Johns Hopkins hospitalist, joins the Clinical Committee. This fills two previously disclosed vacancies and brings the Board to nine directors total.
Why this rating
Board appointments are routine governance; no financial/operational impact disclosed. At $1.1B market cap, immaterial to valuation or strategy.
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.